Yum Lina Yip Sonderegger

Yum Lina Yip Sonderegger has extensive work experience in the pharmaceutical industry. Yum Lina currently serves as the Director of Global Market Access at Otsuka Pharmaceutical Companies Europe. Prior to this role, they worked at Ferring Pharmaceuticals, where they held various positions including Director of Global Market Access and Pricing, Associate Director of Global Market Access and Pricing, and Senior Manager of Global Payer Solutions.

Before joining Ferring Pharmaceuticals, Yum Lina Yip Sonderegger worked at Merck Serono as a Manager and Associate Manager of Global R&D Knowledge Management. Yum Lina also gained research experience at the University of Geneva as a Senior Research Fellow and at the Swiss Institute of Bioinformatics as a Research staff and project leader.

Yum Lina Yip Sonderegger started their career as a Research Officer at St Vincent's Hospital Sydney. Throughout their career, they have focused on market access, pricing strategies, health economics, and decision analysis in various therapeutic areas such as Gastroenterology/Microbiome, Reproductive Medicine, Fertility, Uro-oncology.

Yum Lina Yip Sonderegger has an extensive education history. In 1994, they completed a Bachelor's degree in Biotechnology with First-Class Honours at UNSW. Yum Lina then pursued further education and obtained a PhD in Medicine from UNSW in 2001. Following this, from 2001 to 2002, they attended the University of Geneva and earned a DEA degree in Bioinformatics.

In 2012, Yum Lina Yip Sonderegger enrolled in EPFL (École polytechnique fédérale de Lausanne) to pursue an Executive MBA, specializing in the Management of Technology. Their education concluded in 2013 upon completing the program.

Additionally, Yum Lina Yip Sonderegger holds a Certificate of Professional Training in Medical Informatics, which they obtained from the Université de Genève in 2006. The specific month of attainment for this certification is not provided.